Please note: The information displayed on this page might be outdated.
VantAI: Provider of solutions intended for challenging the boundary of in-silico. The company's core offerings include drug repurposing, in-silico toxicology and adverse event prediction, enabling to uncover organ-specific side effect concerns with unprecedented biological explainability down to the pathway and protein level.
US - Middle Atlantic
New York, NY 10003
Company Participants at 2nd Solebury Trout Virtual Global Healthcare Conference Series
Dr. Zachary Carpenter serves as President at VantAI.